NYSE:RFL - New York Stock Exchange, Inc. - US75062E1064 - Common Stock - Currency: USD
NYSE:RFL (4/23/2025, 3:00:06 PM)
1.66
+0.02 (+1.22%)
The current stock price of RFL is 1.66 USD. In the past month the price decreased by -17.17%. In the past year, price decreased by -3.81%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LB | LANDBRIDGE CO LLC-A | 20.46 | 5.35B | ||
VTMX | CORP INMOBILIARIA VESTA-ADR | 8.49 | 2.22B | ||
IRS | IRSA -SP ADR | N/A | 1.04B | ||
KW | KENNEDY-WILSON HOLDINGS INC | N/A | 890.16M | ||
MRNO | MURANO GLOBAL INVESTMENTS PL | N/A | 768.63M | ||
FRPH | FRP HOLDINGS INC | 78.5 | 509.51M | ||
MLP | MAUI LAND & PINEAPPLE CO | N/A | 306.96M | ||
TCI | TRANSCONTINENTAL REALTY INV | 41.51 | 243.91M | ||
SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 234.95M | ||
OZ | BELPOINTE PREP LLC | N/A | 232.80M | ||
NEN | NEW ENGLAND REALTY ASSOC-LP | 0.59 | 221.20M | ||
LPA | LOGISTIC PROPERTIES OF THE A | N/A | 212.19M |
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-03-12. Its segments include Healthcare, Infusion Technology and Real Estate. The company holds a majority equity interest in LipoMedix Pharmaceuticals Ltd. (a clinical-stage pharmaceutical company), Barer Institute Inc. (a preclinical cancer metabolism research operation), and a majority interest in Cornerstone Pharmaceuticals, Inc. (a cancer metabolism-based therapeutics company). The company holds a majority interest in Rafael Medical Devices, LLC., an orthopedic-focused medical device company, and a majority interest in Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their cannabis offerings enabling them to bring to market predictable versions by utilizing Day Three's pharmaceutical-grade technology and innovation like Unlokt. Its investments include Cyclo Therapeutics Inc. (developing Trappsol Cyclo). The company holds a portion of a commercial building in Israel.
RAFAEL HOLDINGS INC-CLASS B
520 Broad Street
Newark NEW JERSEY 07102 US
CEO: Ameet Mallik
Employees: 13
Company Website: https://rafaelholdings.com
Investor Relations: https://rafaelholdings.irpass.com/
Phone: 12126581450
The current stock price of RFL is 1.66 USD. The price increased by 1.22% in the last trading session.
The exchange symbol of RAFAEL HOLDINGS INC-CLASS B is RFL and it is listed on the New York Stock Exchange, Inc. exchange.
RFL stock is listed on the New York Stock Exchange, Inc. exchange.
RAFAEL HOLDINGS INC-CLASS B (RFL) has a market capitalization of 53.20M USD. This makes RFL a Micro Cap stock.
RAFAEL HOLDINGS INC-CLASS B (RFL) currently has 13 employees.
RAFAEL HOLDINGS INC-CLASS B (RFL) has a support level at 1.6 and a resistance level at 1.7. Check the full technical report for a detailed analysis of RFL support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RFL does not pay a dividend.
RAFAEL HOLDINGS INC-CLASS B (RFL) will report earnings on 2025-06-12.
RAFAEL HOLDINGS INC-CLASS B (RFL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.11).
The outstanding short interest for RAFAEL HOLDINGS INC-CLASS B (RFL) is 0.5% of its float. Check the ownership tab for more information on the RFL short interest.
ChartMill assigns a fundamental rating of 2 / 10 to RFL. While RFL seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months RFL reported a non-GAAP Earnings per Share(EPS) of -2.11. The EPS decreased by -2619.55% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -60.77% | ||
ROE | -72.74% | ||
Debt/Equity | 0.03 |